← Daily Brief
The Bell BriefFrom Dr. Jennifer Bell, DDS MAGD FICD
MEDIUMBusinessTier 1

Carlsquare advised Apheon on its majority acquisition of Hager & Meisinger Group

SourceCarlsquare Corporate FinanceTier 1Mainstream Media

Originally at news.google.com

Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.

Why it matters for dental

Practice owners and DSOs considering a sale or recapitalization should note that Hager & Meisinger Group, a German dental-instrument and implant manufacturer, has changed controlling ownership, which may affect future product availability, pricing, and distribution in U.S. clinics.

Key points

  • Carlsquare advised Apheon on its majority acquisition of Hager & Meisinger Group, a European dental device manufacturer.
  • Apheon, a private-equity firm, gains majority control of Hager & Meisinger, potentially altering long-term strategy, branding, and U.S. channel partnerships.
  • The transaction is reported today, 2026-10-08; no further effective dates or integration timelines are stated.
  • U.S. dental practices that rely on Hager & Meisinger instruments or implants should monitor any announced changes in pricing, warranties, or distributor relationships.

Who should care

OwnerDSO

Read the original on Media: DSOs & private equity

Full reporting and any paywall content live on news.google.com. We summarize and score; we do not republish.

Open original

Related